Rein Therapeutics RNTX
NASDAQ RNTX
$0.80 -0.05 (-6.03%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rein Therapeutics (RNTX) Long-Term Investments (2026)

Updated

Rein Therapeutics' Long-Term Investments came in at $2.98 million for Q2 2026.

Analysis

Rein Therapeutics (RNTX) Long-Term Investments (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 266.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 2.62 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 1.56 Bn
10 Rein Therapeutics 57.02 Mn 57.02 Mn - 2.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.98 Mn
API Access

Rein Therapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=RNTX&period=max&api_key=YOUR_API_KEY